Arama Sonuçları - Frank V. Fossella

Sonuçları Daraltın
  1. 1
    Positron Emission Tomography/Computed Tomography-Guided Intensity-Modulated Radiotherapy for Limited-Stage Small-Cell Lung Cancer

    Positron Emission Tomography/Computed Tomography-Guided Intensity-Modulated Radiotherapy for Limited-Stage Small-Cell Lung Cancer Yazar: Shervin M. Shirvani, Ritsuko Komaki, John V. Heymach, Frank V. Fossella, Joe Y. Chang

    Baskı/Yayın Bilgisi 2011
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  2. 2
    P2-328: Is pemetrexed more effective in adenocarcinoma and large cell lung cancer than in squamous cell carcinoma? A retrospective analysis of a phase III trial of pemetrexed vs docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC)

    P2-328: Is pemetrexed more effective in adenocarcinoma and large cell lung cancer than in squamous cell carcinoma? A retrospective analysis of a phase III trial of pemetrexed vs do... Yazar: Patrick Peterson, Keunchil Park, Frank V. Fossella, U. Gatzemeier, William J. John, Giorgio V. Scagliotti

    Baskı/Yayın Bilgisi 2007
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  3. 3
    Differences in attitudes and beliefs toward end-of-life care between hematologic and solid tumor oncology specialists

    Differences in attitudes and beliefs toward end-of-life care between hematologic and solid tumor oncology specialists Yazar: David S.C. Hui, Swati Bansal, M. Park, Akhila Reddy, Jorge E. Cortés, Frank V. Fossella, Éduardo Bruera

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  4. 4
    Phase II, Multicenter, Uncontrolled Trial of Single-Agent Sorafenib in Patients With Relapsed or Refractory, Advanced Non–Small-Cell Lung Cancer

    Phase II, Multicenter, Uncontrolled Trial of Single-Agent Sorafenib in Patients With Relapsed or Refractory, Advanced Non–Small-Cell Lung Cancer Yazar: George R. Blumenschein, U. Gatzemeier, Frank V. Fossella, David J. Stewart, Lisa Cupit, Frank Cihon, James J. O’Leary, Martin Reck

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  5. 5
    The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies

    The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies Yazar: Giorgio V. Scagliotti, Nasser H. Hanna, Frank V. Fossella, Katherine P. Sugarman, J. Blatter, Patrick Peterson, Lorinda Simms, Frances A. Shepherd

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  6. 6
    Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors

    Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors Yazar: Manisha H. Shah, Paul Lorigan, Mary O’Brien, Frank V. Fossella, Kathleen N. Moore, Shailender Bhatia, Maurice Kirby, Penella J. Woll

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  7. 7
    Comparison of Docetaxel- and Vinca Alkaloid–Based Chemotherapy in the First-line Treatment of Advanced Non-small Cell Lung Cancer: A Meta-analysis of Seven Randomized Clinical Trials

    Comparison of Docetaxel- and Vinca Alkaloid–Based Chemotherapy in the First-line Treatment of Advanced Non-small Cell Lung Cancer: A Meta-analysis of Seven Randomized Clinical Tria... Yazar: Jean‐Yves Douillard, Silvy Laporte, Frank V. Fossella, Vassilis Georgoulias, Jean-Louis Pujol, Kaoru Kubota, Alain Monnier, Shinzoh Kudoh, Jaime Ernesto Rubio, Michel Cucherat

    Baskı/Yayın Bilgisi 2007
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  8. 8
    Phase II Study of Cetuximab in Combination With Chemoradiation in Patients With Stage IIIA/B Non–Small-Cell Lung Cancer: RTOG 0324

    Phase II Study of Cetuximab in Combination With Chemoradiation in Patients With Stage IIIA/B Non–Small-Cell Lung Cancer: RTOG 0324 Yazar: George R. Blumenschein, Rebecca Paulus, Walter J. Curran, Francisco Robert, Frank V. Fossella, Maria Werner‐Wasik, Roy S. Herbst, P. Doescher, Hak Choy, Ritsuko Komaki

    Baskı/Yayın Bilgisi 2011
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  9. 9
    Treatment-by-Histology Interaction Analyses in Three Phase III Trials Show Superiority of Pemetrexed in Nonsquamous Non-small Cell Lung Cancer

    Treatment-by-Histology Interaction Analyses in Three Phase III Trials Show Superiority of Pemetrexed in Nonsquamous Non-small Cell Lung Cancer Yazar: Giorgio V. Scagliotti, Thomas Brodowicz, Frances A. Shepherd, Christoph Zielinski, Johan Vansteenkiste, Christian Manegold, Lorinda Simms, Frank V. Fossella, Katherine P. Sugarman, Chandra P. Belani

    Baskı/Yayın Bilgisi 2010
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  10. 10
    Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: An Individual Patient Data Meta-analysis

    Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: An Individual Patient Data Meta-analysis Yazar: Andrea Ardizzoni, Luca Boni, Marcello Tiseo, Frank V. Fossella, Joan H. Schiller, Marianne Paesmans, Davorin Radosavljević, Adriano Paccagnella, Petr Zatloukal, Paola Mazzanti, D. Bisset, R. Rosell

    Baskı/Yayın Bilgisi 2007
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  11. 11
    Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trials

    Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised tri... Yazar: Silvy Laporte, Pierre Squifflet, Noémie Baroux, Frank V. Fossella, Vassilis Georgoulias, Jean-Louis Pujol, Jean‐Yves Douillard, Shinzohy Kudoh, Jean‐Pierre Pignon, Emmanuel Quinaux, Marc Buyse

    Baskı/Yayın Bilgisi 2013
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  12. 12
    Lung Cancer Symptom Scale Outcomes in Relation to Standard Efficacy Measures: An Analysis of the Phase III Study of Pemetrexed Versus Docetaxel in Advanced Non-small Cell Lung Cancer

    Lung Cancer Symptom Scale Outcomes in Relation to Standard Efficacy Measures: An Analysis of the Phase III Study of Pemetrexed Versus Docetaxel in Advanced Non-small Cell Lung Canc... Yazar: Filippo de Marinis, José Rodrigues Pereira, Frank V. Fossella, Michael C. Perry, Martin Reck, Marc Salzberg, Jacek Jassem, Patrick Peterson, Astra M. Liepa, Patti Moore, Richard J. Gralla

    Baskı/Yayın Bilgisi 2008
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  13. 13
    The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer

    The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer Yazar: Glen J. Weiss, Rafael Rosell, Frank V. Fossella, Michael C. Perry, Rolf A. Stahel, Fernando Barata, Binh Nguyen, S. Paul, P. McAndrews, Nasser H. Hanna, Karen Kelly, P. A. Bunn

    Baskı/Yayın Bilgisi 2007
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  14. 14
    Phase II study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in patients with taxane‐refractory/resistant nonsmall cell lung carcinoma

    Phase II study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in patients with taxane‐refractory/resistant nonsmall cell lung carcinoma Yazar: Edward S. Kim, Merrill S. Kies, Frank V. Fossella, Bonnie S. Glisson, Sara Zaknoen, Paul Statkevich, Reginald F. Munden, Carmen Summey, Katherine M.W. Pisters, Vali Papadimitrakopoulou, Mourad Tighiouart, André Rogatko, Fadlo R. Khuri

    Baskı/Yayın Bilgisi 2005
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  15. 15
    Dexamethasone for Dyspnea in Cancer Patients: A Pilot Double-Blind, Randomized, Controlled Trial

    Dexamethasone for Dyspnea in Cancer Patients: A Pilot Double-Blind, Randomized, Controlled Trial Yazar: David Hui, Kelly Kilgore, Susan Frisbee‐Hume, Minjeong Park, Anne S. Tsao, Marvin Delgado Guay, Charles Lu, William William, Katherine M.W. Pisters, George A. Eapen, Frank V. Fossella, Sapna Amin, Éduardo Bruera

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  16. 16
    Phase II Trial of Cediranib in Combination With Cisplatin and Pemetrexed in Chemotherapy-Naïve Patients With Unresectable Malignant Pleural Mesothelioma (SWOG S0905)

    Phase II Trial of Cediranib in Combination With Cisplatin and Pemetrexed in Chemotherapy-Naïve Patients With Unresectable Malignant Pleural Mesothelioma (SWOG S0905) Yazar: Anne S. Tsao, Jieling Miao, Ignacio I. Wistuba, Nicholas J. Vogelzang, John V. Heymach, Frank V. Fossella, Charles Lu, Mario R. Velasco, Brandy Box-Noriega, James Gilbert Hueftle, Shirish M. Gadgeel, Mary W. Redman, David R. Gandara, Karen Kelly

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  17. 17
    Phase II study of pemetrexed in combination with carboplatin in the first‐line treatment of advanced nonsmall cell lung cancer

    Phase II study of pemetrexed in combination with carboplatin in the first‐line treatment of advanced nonsmall cell lung cancer Yazar: Ralph Zinner, Frank V. Fossella, Gregory W. Gladish, Bonnie S. Glisson, George R. Blumenschein, Vassiliki A. Papadimitrakopoulou, Katherine M.W. Pisters, Edward S. Kim, Yun Oh, Beverly O. Peeples, Zhishen Ye, Rafael E. Curiel, Coleman K. Obasaju, Waun Ki Hong, Roy S. Herbst

    Baskı/Yayın Bilgisi 2005
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  18. 18
    Poziotinib for Patients With <i>HER2</i> Exon 20 Mutant Non–Small-Cell Lung Cancer: Results From a Phase II Trial

    Poziotinib for Patients With <i>HER2</i> Exon 20 Mutant Non–Small-Cell Lung Cancer: Results From a Phase II Trial Yazar: Yasir Y. Elamin, Jacqulyne Robichaux, Brett W. Carter, Mehmet Altan, Don L. Gibbons, Frank V. Fossella, Vincent K. Lam, Anisha B. Patel, Marcelo V. Negrão, Xiuning Le, Frank E. Mott, Jianjun Zhang, Lei Feng, George R. Blumenschein, Anne S. Tsao, John V. Heymach

    Baskı/Yayın Bilgisi 2021
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  19. 19
    Small Cell Lung Cancer

    Small Cell Lung Cancer Yazar: Gregory P. Kalemkerian, Wallace Akerley, Robert J. Downey, David S. Ettinger, Frank V. Fossella, J.C. Grecula, Thierry Jahan, Bruce E. Johnson, Anne Kessinger, Marianna Koczywas, Corey J. Langer, Renato Martins, Harvey B. Niell, Charles C. Pan, Nithya Ramnath, Neal Ready, Francisco Robert, Charles C. Williams

    Baskı/Yayın Bilgisi 2013
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  20. 20
    Randomized Phase II Study of Bortezomib Alone and Bortezomib in Combination With Docetaxel in Previously Treated Advanced Non–Small-Cell Lung Cancer

    Randomized Phase II Study of Bortezomib Alone and Bortezomib in Combination With Docetaxel in Previously Treated Advanced Non–Small-Cell Lung Cancer Yazar: Michael Fanucchi, Frank V. Fossella, Robert J. Belt, Ronald Natale, Panos Fidias, David P. Carbone, Ramaswamy Govindan, Luis E. Raez, Francisco Robert, Maria Ribeiro, Wallace Akerley, Karen Kelly, Steven Limentani, Jeffrey Crawford, Hans-Joachim Reimers, Rita Axelrod, Oscar Kashala, Shihong Sheng, Joan H. Schiller

    Baskı/Yayın Bilgisi 2006
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: